Contact
Please use this form to send email to PR contact of this press release:
Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction, Epilepsy and Multiple Sclerosis
TO:
Please use this form to send email to PR contact of this press release:
Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction, Epilepsy and Multiple Sclerosis
TO: